ATE419872T1 - Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene - Google Patents

Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene

Info

Publication number
ATE419872T1
ATE419872T1 AT01907203T AT01907203T ATE419872T1 AT E419872 T1 ATE419872 T1 AT E419872T1 AT 01907203 T AT01907203 T AT 01907203T AT 01907203 T AT01907203 T AT 01907203T AT E419872 T1 ATE419872 T1 AT E419872T1
Authority
AT
Austria
Prior art keywords
monoclonal antibodies
vacciniavirus
preventive
antigens
antibodies against
Prior art date
Application number
AT01907203T
Other languages
English (en)
Inventor
Jay Hooper
Alan Schmaljohn
Connie Schmaljohn
Original Assignee
U S Army Medical Res Inst Of I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by U S Army Medical Res Inst Of I filed Critical U S Army Medical Res Inst Of I
Application granted granted Critical
Publication of ATE419872T1 publication Critical patent/ATE419872T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01907203T 2000-02-11 2001-02-09 Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene ATE419872T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18206600P 2000-02-11 2000-02-11

Publications (1)

Publication Number Publication Date
ATE419872T1 true ATE419872T1 (de) 2009-01-15

Family

ID=22666929

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01907203T ATE419872T1 (de) 2000-02-11 2001-02-09 Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene

Country Status (6)

Country Link
US (2) US6451309B2 (de)
EP (1) EP1309348B1 (de)
AT (1) ATE419872T1 (de)
AU (1) AU2001235006A1 (de)
DE (1) DE60137337D1 (de)
WO (1) WO2001058485A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000275666A (ja) * 1999-03-25 2000-10-06 Hitachi Ltd 液晶表示装置
EP1474449A4 (de) * 2002-02-11 2005-10-12 Alexion Pharma Inc Humane antikörper zur verwendung als therapeutisches mittel gegen vaccinia bzw. pocken
US6982156B2 (en) * 2002-03-27 2006-01-03 Trustees Of The University Of Pennsylvania Compositions and methods modulating variola and vaccinia virus
GB0212666D0 (en) 2002-05-31 2002-07-10 Secr Defence Immunogenic sequences
US20060003316A1 (en) * 2002-07-15 2006-01-05 John Simard Immunogenic compositions derived from poxviruses and methods of using same
WO2004053454A2 (en) * 2002-11-27 2004-06-24 Government Of The United States Of America As Represented By The Sercretary Of The Department Of Health And Human Services National Institutes Of Health Methods for detecting invasion of a cell
US20040185022A1 (en) * 2003-02-19 2004-09-23 Steven Rubin Regimen for acne treatment
AU2004262506A1 (en) * 2003-02-28 2005-02-17 National Institutes Of Health Compositions, methods and kits relating to poxvirus subunit vaccines
WO2005003325A2 (en) * 2003-03-11 2005-01-13 Dana Farber Cancer Institute Inhibition of viral pathogenesis
US20050009110A1 (en) * 2003-07-08 2005-01-13 Xiao-Jia Chang Methods of producing antibodies for diagnostics and therapeutics
AU2005255019B2 (en) * 2004-06-12 2011-05-19 Oregon Health And Science University Compositions and methods for diagnosis and treatment of orthopoxviruses
KR101699142B1 (ko) * 2004-06-18 2017-01-23 암브룩스, 인코포레이티드 신규 항원-결합 폴리펩티드 및 이의 용도
RU2281327C2 (ru) * 2004-09-01 2006-08-10 Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" ШТАММ ГИБРИДНЫХ КУЛЬТИВИРУЕМЫХ КЛЕТОК Rattus norvegicus 122Н9 - ПРОДУЦЕНТ ПЕРЕКРЕСТНО-РЕАКТИВНЫХ НЕЙТРАЛИЗУЮЩИХ МОНОКЛОНАЛЬНЫХ АНТИТЕЛ ПРОТИВ ОРТОПОКСВИРУСОВ, ПАТОГЕННЫХ ДЛЯ ЧЕЛОВЕКА
US7393533B1 (en) * 2004-11-08 2008-07-01 La Jolla Institute For Allergy And Immunology H3L envelope protein immunization methods and H3L envelope passive protection methods
US20090087456A1 (en) * 2005-09-07 2009-04-02 James Edward Eyles Adjuvanted vaccine
US7790182B2 (en) * 2005-09-21 2010-09-07 The United States Of America As Represented By The Secretary Of The Army Protein vaccines against poxviruses
US7850965B2 (en) * 2005-12-05 2010-12-14 Symphogen A/S Anti-orthopoxvirus recombinant polyclonal antibody
GB2453475B (en) 2006-07-25 2011-01-19 Secr Defence Live vaccine strain
CN101553255A (zh) * 2006-08-23 2009-10-07 奎尔斯根制药有限责任公司 天花单克隆抗体
EP2121720A4 (de) 2007-02-12 2010-05-12 Us Army Dna-impfstoffe auf basis von puumala-virus m-segmenten mit voller länge
EP2167123A4 (de) * 2007-07-09 2012-09-05 Usa As Represented By The Secretary Of The Army On Behalf Of The United States Army Medical Res Zusammensetzungen mit l1r-nukleinsäure mit voller länge und einer sequenz zum targeting des endoplasmischen retikulums
RU2342951C1 (ru) * 2007-09-12 2009-01-10 Федеральное государственное "48 Центральный научно-исследовательский институт Министерства обороны Российской Федерации" Препарат, содержащий иммуноглобулин противооспенный из сыворотки крови лошадей, раствор для внутримышечного введения
US8795667B2 (en) * 2007-12-19 2014-08-05 Macrogenics, Inc. Compositions for the prevention and treatment of smallpox
GB0906234D0 (en) 2009-04-14 2009-05-20 Secr Defence Vaccine
US9315826B2 (en) 2011-01-31 2016-04-19 The United States of America as rep. by the Sec'y of the Army, for U.S. Army Medical Research Institute of Infectious Diseases Nucleic acids containing a synthetic codon-optimized Sin Nombre virus full-length M gene
US9861681B2 (en) 2013-04-18 2018-01-09 The United States of America as represented by the Secretary of the Army, on behalf of the United States Army Medical Research Institute of Infectious Diseases Therapeutic compositions for neutralizing type I interferons, and methods of use
DE102015107577A1 (de) * 2015-05-13 2016-11-17 Osram Opto Semiconductors Gmbh Optoelektronischer Halbleiterchip
US10381278B2 (en) * 2017-09-14 2019-08-13 Powertech Technology Inc. Testing method of packaging process and packaging structure
IL300836A (en) * 2023-02-21 2024-09-01 State Of Israel Israel Institute For Biological Res Antibodies against Pox viruses
CN120665190B (zh) * 2025-08-21 2025-10-28 中国人民解放军军事科学院军事医学研究院 抗正痘病毒中和性单克隆抗体b36b9及应用

Also Published As

Publication number Publication date
AU2001235006A1 (en) 2001-08-20
DE60137337D1 (de) 2009-02-26
US20020009447A1 (en) 2002-01-24
US6451309B2 (en) 2002-09-17
WO2001058485A2 (en) 2001-08-16
US20030022226A1 (en) 2003-01-30
EP1309348B1 (de) 2009-01-07
EP1309348A2 (de) 2003-05-14
WO2001058485A3 (en) 2002-01-10
US6620412B2 (en) 2003-09-16

Similar Documents

Publication Publication Date Title
ATE419872T1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
CY2020003I1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
CY1117387T1 (el) ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ
ATE507839T1 (de) Kombinationstherapie
BR0309665A (pt) Tratamento de deficiência de alfa-galactosidase a
NO20044039L (no) Konjugatorer av terapeutiske eller cytotoksiske midler og biologisk aktive peptider.
CY1112055T1 (el) Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα
DE60033530D1 (de) Humane antikörper gegen ctla-4 und deren verwendungen
ATE556706T1 (de) Fettalkohol-arzneimittel-konjugate
BR9707819A (pt) Imunogenos peptidicos
BR0315157A (pt) Métodos de tratar doença de alzheimer empregando-se anticorpos direcionados contra peptìdeo beta amilóide e composições deste
NO20034056D0 (no) Proliferative sykdommer
EP1537146A4 (de) Ausgewählte antikörper und duramycin-peptide mit bindung an anionische phospholipide und aminophospholipide und ihre verwendung bei der behandlung von virusinfektionen und krebs
WO2004018649A3 (en) Monoclonal antibodies and complementarity-determining regions binding to ebola glycoprotein
CY1108020T1 (el) Μονοκλωνικα αντισωματα στον ανθρωπινο υποδοχεα ldl, η παραγωγη και χρηση τους
DE69938935D1 (de) Zyklische conotoxin-peptide
CY1114614T1 (el) Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
EP0932613A4 (de) Expressionsblockierung von virulenten faktoren in s. aureus
IL163900A (en) Antibody which binds to tpte for use in diagnosing, monitoring, preventing or treating cancer disease and pharmaceutical compositions comprising said antibody
EA200400134A1 (ru) Терапевтический агент
DOP2002000451A (es) Nuevas ciclohexilsulfonas (agentes terapéuticos)
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
DE60229624D1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties